首页> 外文OA文献 >Analysis of sub-visible particles in complex injectable formulations
【2h】

Analysis of sub-visible particles in complex injectable formulations

机译:复杂的可注射制剂中亚可见颗粒的分析

摘要

Complex injectable formulations, such as protein therapeutics, controlled release systems and cell therapy products, are gaining a paramount position in the therapy of many life-threatening and chronic diseases. Most of these products have in common that sub-visible particles (SVP), i.e., particulate matter in the size range of about 1 – 100 µm, are criticalquality attributes. Most protein therapeutics are liquid or freeze-dried formulations in which the presence of SVP is unwanted; many injectable controlled release systems are based on particulate drug delivery systems in the sub-visible size range; and cell concentration and viability are important characteristics of cell therapy products. With the continuousimprovement of existing and emerging particle analysis techniques, the potentials of these tools in addressing current characterization challenges in the field of complex injectable formulations have to be investigated. Therefore, the aim of this thesis was to develop methods, based on a set of state-of-the-art particle analysis techniques, for characterization of pharmaceutically relevant sub-visible particles and to study the value of these methods in the characterization of complex injectable formulations.
机译:复杂的可注射制剂,例如蛋白质治疗剂,控释系统和细胞治疗产品,在许多威胁生命和慢性疾病的治疗中正变得至关重要。这些产品大多数都有一个共同点,那就是亚可见颗粒(SVP),即尺寸范围在1 – 100 µm左右的颗粒物,是关键质量属性。大多数蛋白质治疗剂是不需要SVP的液体或冻干制剂。许多可注射的控释系统都是基于亚可见尺寸范围内的颗粒药物输送系统。细胞浓度和活力是细胞治疗产品的重要特征。随着现有和新兴颗粒分析技术的不断改进,必须研究这些工具在解决复杂的可注射制剂领域中当前表征挑战方面的潜力。因此,本论文的目的是基于一系列最新的颗粒分析技术,开发用于表征药物相关的亚可见颗粒的方法,并研究这些方法在复杂化合物的表征中的价值。注射剂。

著录项

  • 作者

    Sediq A.S.;

  • 作者单位
  • 年度 2017
  • 总页数
  • 原文格式 PDF
  • 正文语种
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号